Clarus Ventures
Venture capital · Cambridge, Massachusetts, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
7Deep-tech portfolio1 active
6Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Cidara Therapeutics
39Co-investorsShare a portfolio company
Portfolio · 7 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Navitor Pharmaceuticals | Biotech | Active | May 7, 2020 | $64.9M |
| Cidara Therapeutics | Biotech | Acquired | May 6, 2024 | $349.1M |
| Relay Therapeutics | Biotech | Public | Jan 10, 2024 | $30.0M |
| Dimension Therapeutics | Biotech | Acquired | Apr 23, 2015 | $70.0M |
| Corbus Pharmaceuticals | Biotech | Public | — | — |
| Tetraphase Biosciences | Biotech | Acquired | — | — |
| Turning Point Therapeutics | Biotech | Acquired | — | — |
Peer ranks
Portfolio size#60
Portfolio exits#31
Raises, 12 months#88
Co-investors#47
Co-investors
- Third Rock VenturesVenture capital3 shared
- Bay City CapitalVenture capital2 shared
- Biotechnology Value FundVenture capital2 shared
- Boxer CapitalVenture capital2 shared
- Brookside CapitalVenture capital2 shared
- EcoR1 CapitalVenture capital2 shared
- Gurnet Point CapitalVenture capital2 shared
- Mission Bay CapitalVenture capital2 shared
- Omega FundsVenture capital2 shared
- RA CapitalVenture capital2 shared
Sectors
- Biotech7
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.